Cytophil, Inc.

Form 483 issued July 29, 2022 · East Troy, Wisconsin

Inspection
Jul 25 – Jul 29, 2022
Investigator
Nicholas Z. Lu
Observations
5
Pages
6
FEI number
3007225376

In short: On July 29, 2022, FDA issued a Form 483 with 5 observations to Cytophil, Inc. in East Troy, Wisconsin (FEI 3007225376) after an inspection that ran Jul 25 – Jul 29, 2022. The investigator was Nicholas Z. Lu. Most observations concern production & process controls and cAPA.

At a glance

Production & process controls and capa account for 4 of 5 observations.

Production & process controls2
CAPA2
Design controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

  2. 02

    Procedures have not been adequately established to control product that does not…

  3. 03

    Procedures to ensure sampling methods are adequate for their intended use have…

  4. 04

    Procedures for corrective and preventive action have…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Cytophil, Inc.?

FDA listed 5 observations on this Form 483, mostly about production & process controls, cAPA and design controls. The opening words of each observation are shown on this page.

Who inspected Cytophil, Inc.?

Nicholas Z. Lu is named on this Form 483, for the inspection of Jul 25 – Jul 29, 2022. Each investigator has a profile showing what they cite most.

When was Cytophil, Inc. inspected by FDA?

The inspection ran Jul 25 – Jul 29, 2022, and the Form 483 is dated July 29, 2022.

How do I get the full Form 483 for Cytophil, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free